Patent Application: Reducing Fasting Blood Glucose Using Plants

ChangeBridge: Patent Apps - Therapeutics (A61P)

Published September 26th, 2024

Detected March 27th, 2026

Summary

The USPTO has published a new patent application detailing methods and compositions for reducing fasting blood glucose using plants like Dichrostachys glomerata or Cissus quadrangularis. The application, filed on September 26, 2024, describes oral dosage forms for health benefits including increased GLP-1 levels and reduced blood lipids.

View original document View source feed page

What changed

This document is a publication of a new patent application (US20260083812A1) filed with the USPTO on September 26, 2024. The application describes methods and compositions utilizing specific plants, Dichrostachys glomerata or Cissus quadrangularis, to reduce fasting blood glucose in mammals. It also claims benefits such as increased GLP-1 levels, reduced visceral fat, and decreased blood lipids, presented in various oral dosage forms.

As this is a patent application, it does not impose immediate regulatory obligations on companies. However, it signals potential future intellectual property in the therapeutic area of glucose management and related health benefits. Companies operating in the pharmaceutical or nutraceutical sectors should be aware of this filing for competitive intelligence and potential licensing or infringement considerations.

Source document (simplified)

← USPTO Patent Applications

METHODS AND COMPOSITIONS FOR REDUCING FASTING BLOOD GLUCOSE IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES

Application US20260083812A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari, Julius Enyoug Oben

Abstract

Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing fasting blood glucose in a mammal is provided where the composition comprises an effective amount of Cissus quadrangularis provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.